The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
about
Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytesGlutamate transporter 1: target for the treatment of alcohol dependenceExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsGlutamate Transporter GLT-1 as a Therapeutic Target for Substance Use DisordersClavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug?beta-Lactam antibiotic inhibits development of morphine physical dependence in rats.Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes.Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring ratsUp-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouseRole of the major glutamate transporter GLT1 in nucleus accumbens core versus shell in cue-induced cocaine-seeking behaviorEffects of Ceftriaxone on Glial Glutamate Transporters in Wistar Rats Administered Sequential Ethanol and MethamphetamineEffects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice.Effects of opioids, cannabinoids, and vanilloids on body temperature.Effects of ceftriaxone on conditioned nicotine reward in rats.Glutamate transporter activation enhances nicotine antinociception and attenuates nicotine analgesic tolerance.Effects of Low-Dose Escherichia coli Lipopolysaccharide-Induced Endotoxemia on Morphine Pharmacokinetics in an Animal Model.Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation.Glial and neuroinflammatory targets for treating substance use disorders.Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus.
P2860
Q24648789-41D35346-55BF-48B4-8422-5BB58DFFFBC1Q26861666-ACF4C3C6-9F48-420A-8526-E6CFFB494588Q28075692-2732DB6B-05F8-4B86-92D8-D258BB18FEAAQ28081726-1A4B1B5E-6020-4DDB-A636-688DF7461290Q34021956-CB3AA5AB-AB8D-4FF3-B7B0-23BE099042FFQ34072503-72C1DB09-472A-4E55-8B51-D7A6E3463D39Q35111621-0CEAC671-7D6E-4303-B76A-713BB9D660EBQ35956322-F0AB5B33-058C-4E18-89D9-55995C41003CQ36713909-C6D7A9BB-BDDB-43C6-95D8-69339C5FED79Q36959660-D2E2E3F5-2CBB-4964-B853-D0E64362C90EQ37273362-E6ADA79A-CAB0-4E6D-83B7-F285A36E5642Q37291940-EBDF789A-8E30-4CE4-99E3-C0EAFBA1B4BBQ37692352-6EB9CD67-BE32-4799-9A52-E81517B7E8C9Q38680967-B8E8272C-4AC6-44B2-A59E-3A93DAC96599Q39303961-7A540C88-CA21-4AF2-A87A-17C37C35AC99Q40057969-8BAD2207-D687-41E2-B063-C10899EBD343Q42533948-B6231844-7DED-4069-ABD0-00734AC088A6Q43076075-75608CF9-707C-4BB7-A0B2-9DBF32841C4FQ48273821-28BADCC5-3033-4A98-93DA-94EAFDDBBF6D
P2860
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
@ast
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
@en
type
label
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
@ast
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
@en
prefLabel
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
@ast
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
@en
P2093
P2860
P356
P1476
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0707309
P407
P577
2007-06-25T00:00:00Z